OXB.L

Oxford Biomedica plc
LSEGBpEQUITY Healthcare DELAYED
Last price
509.00
▼ 17.00 (3.23%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
530.00
Prev close
526.00
Day high
530.00
Day low
503.00
Volume
285.69K
Market cap
$616.12M
P/E (TTM)
52W range
441.50 – 962.00

Day trading desk

Current session · delayed
Gap from prior close
+0.76%
Prior close 526.00
VWAP
509.77
-0.15% from price
Relative volume
0.75×
Normal
Session range
5.37%
503.00 – 530.00
Position in range
22%
Near session low
ATR (14D)
30.41
5.98% of price
Prior day high
527.00
PDH
Prior day low
505.00
PDL
Bid / ask spread
Quote not published
Session volume
413.55K
Avg 554.90K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+3.25% +4.4%
1M
-10.86% -14.2%
3M
-18.30% -20.8%
6M
-34.24% -46.2%
YTD
-17.50% -29.5%
1Y
-8.45% -28.7%
3Y
+59.56% -15.5%
5Y
-64.90%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on OXB.L open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
24.81M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jul 22, 26
M & G Investment Management, Ltd.
100.00K Direct
Jul 13, 26
M & G Investment Management, Ltd.
99.21K Direct
Jul 7, 26
M & G Investment Management, Ltd.
364.51K Direct
May 22, 26
Doman (Lisa)
3.56K Direct
May 22, 26
Doman (Lisa)
SELL 3.56K $29.43K Direct
May 22, 26
Walter (Natalie)
3.82K Direct
May 22, 26
Walter (Natalie)
SELL 3.82K $31.51K Direct
May 18, 26
Miller (Kathleen)
4.49K Direct
May 18, 26
Miller (Kathleen)
SELL 1.58K $12.91K Direct
May 12, 26
Doman (Lisa)
10.59K Direct
May 12, 26
Doman (Lisa)
BUY 2.71K $18.22K Direct
May 12, 26
Doman (Lisa)
SELL 13.30K $114.31K Direct
May 12, 26
Walter (Natalie)
EXERCISE 3.06K $12.17K Direct
May 12, 26
Walter (Natalie)
SELL 3.06K $26.44K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
BlackRock Advisors (UK) Limited
3.39M Bought
Briarwood Chase Management L.L.C.
18.64M Annual Return
Columbia Threadneedle Investments (UK)
3.76M Annual Return
Hargreaves Lansdown Asset Management Ltd.
3.48M Annual Return
Institut Merieux SA
13.02M Annual Return
M & G Investment Management, Ltd.
6.26M Increase
Novo Nordisk A/S
13.46M Annual Return
Serum Life Sciences Ltd
3.77M Annual Return
Shah (Sobhagchand Meghji Hirji)
2.86M Holding
Vitruvian Partners LLP
3.00M Holding

Fundamentals

TTM · reported
Market cap$616.12M
Enterprise value$686.39M
Revenue (TTM)$168.74M
Gross profit$65.98M
EBITDA$-18.26M
Net income$-30.13M
EPS (TTM)$-0.27
Free cash flow$-13.25K
Total cash$96.90M
Total debt$148.13M
Book value / share$0.76
Shares outstanding121.04M
Float60.86M
Short % of float
Dividend yield
Beta (5Y)1.10

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E-121.71
PEG ratio
Price / sales
Price / book673.28
EV / revenue4.07
EV / EBITDA-37.59
Gross margin39.10%
Operating margin-7.88%
Profit margin-17.85%
Return on equity-40.37%
Return on assets-6.97%
Debt / equity162.16
Current ratio2.20
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 3 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $168.74M$128.80M$89.54M$139.99M +31.0%
Operating revenue $168.74M$128.80M$89.54M$139.99M +31.0%
Cost of revenue $102.76M$75.78M$49.81M$70.81M +35.6%
Gross profit $65.98M$53.02M$39.73M$69.18M +24.4%
Research & development $5.06M$4.54M$11.47M$60.94M +11.4%
Selling, general & admin $36.76M$29.42M$26.89M$28.22M +24.9%
Total operating expense $98.94M$96.52M$127.84M$120.74M +2.5%
Operating income -$32.96M-$43.50M-$88.11M-$51.56M +24.2%
Net interest income -$9.32M-$7.27M-$6.29M-$7.78M -28.2%
Pre-tax income -$31.94M-$47.27M-$188.53M-$45.98M +32.4%
Tax provision -$1.29M$1.34M-$4.37M-$817.00K -196.1%
Net income -$30.13M-$43.19M-$157.49M-$39.16M +30.2%
Net income to common -$30.13M-$43.19M-$157.49M-$39.16M +30.2%
Basic EPS -0.27-41.75-1.63-0.41 +99.4%
Diluted EPS -0.27-41.75-1.63-0.41 +99.4%
EBIT -$17.43M-$36.76M-$177.33M-$37.22M +52.6%
EBITDA $2.41M-$14.33M-$148.62M-$10.86M +116.8%
Basic shares 111.92M103.46M96.56M94.83M +8.2%
Diluted shares 111.92M103.46M96.56M94.83M +8.2%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year -0.21 7 $193.88M +14.9%
Next year -0.04 7 $242.32M +25.0%

Analyst targets & ownership

Account required
Mean target$712.00
High target$900.00
Low target$508.00
Implied upside39.88%
Analyst count8
ConsensusBUY
Strong buy / Buy1 / 4
Hold3
Sell / Strong sell0 / 0
Held by insiders20.55%
Held by institutions55.25%
Institutions holding69
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
498.40
+2.13% from price
SMA 20
524.33
-2.92% from price
SMA 50
578.53
-12.02% from price
SMA 100
594.30
-14.35% from price
SMA 200
640.85
-20.57% from price
EMA 12
512.66
-0.71% from price
EMA 26
535.79
-5.00% from price
EMA 50
562.27
-9.47% from price
RSI (14)
41.4
Neutral
MACD (12,26,9)
-23.13
Hist 2.92
ATR (14)
30.41
5.98% of price
Realised vol 30D
57.3%
Annualised
Bollinger upper
595.10
20, 2σ
Bollinger lower
453.55
20, 2σ
50 / 200 cross
Death
578.53 vs 640.85
Trend bias
Below 200
-20.57%

Options chain

Account required
Expiry
Spot 509.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.31
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
57.3%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-47.6%
Peak to trough
Max drawdown 5Y
-89.8%
Peak to trough
ATR 14
30.41
5.98% of price
Beta (reported)
1.10
5Y monthly, from filing

Dividends & splits

Declared · from the issuer
Forward rate
Forward yield
5-year avg yield
Payout ratio0.00%
Ex-dividend date
Next pay date
Last split1:50
Split dateMay 30, 2018

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.